The correlation between SEZ6L2 and reduced CD8+ T cell presence in the tumor microenvironment indicates that it may contribute to immune escape mechanisms, thereby facilitating tumor growth and resistance to immunotherapy. This evidence concerns the gene SEZ6L2 and neoplasm.